292 related articles for article (PubMed ID: 16500983)
1. Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell.
German MJ; Hammiche A; Ragavan N; Tobin MJ; Cooper LJ; Matanhelia SS; Hindley AC; Nicholson CM; Fullwood NJ; Pollock HM; Martin FL
Biophys J; 2006 May; 90(10):3783-95. PubMed ID: 16500983
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of zone-specific spectral signatures in normal human prostate using Raman spectroscopy.
Patel II; Martin FL
Analyst; 2010 Dec; 135(12):3060-9. PubMed ID: 20949203
[TBL] [Abstract][Full Text] [Related]
3. Segregation of human prostate tissues classified high-risk (UK) versus low-risk (India) for adenocarcinoma using Fourier-transform infrared or Raman microspectroscopy coupled with discriminant analysis.
Patel II; Trevisan J; Singh PB; Nicholson CM; Krishnan RK; Matanhelia SS; Martin FL
Anal Bioanal Chem; 2011 Aug; 401(3):969-82. PubMed ID: 21643857
[TBL] [Abstract][Full Text] [Related]
4. Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study.
Gazi E; Dwyer J; Gardner P; Ghanbari-Siahkali A; Wade AP; Miyan J; Lockyer NP; Vickerman JC; Clarke NW; Shanks JH; Scott LJ; Hart CA; Brown M
J Pathol; 2003 Sep; 201(1):99-108. PubMed ID: 12950022
[TBL] [Abstract][Full Text] [Related]
5. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.
John K; Ragavan N; Pratt MM; Singh PB; Al-Buheissi S; Matanhelia SS; Phillips DH; Poirier MC; Martin FL
Prostate; 2009 Apr; 69(5):505-19. PubMed ID: 19143007
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
7. Fourier transform infrared microspectroscopy identifies symmetric PO(2)(-) modifications as a marker of the putative stem cell region of human intestinal crypts.
Walsh MJ; Fellous TG; Hammiche A; Lin WR; Fullwood NJ; Grude O; Bahrami F; Nicholson JM; Cotte M; Susini J; Pollock HM; Brittan M; Martin-Hirsch PL; Alison MR; Martin FL
Stem Cells; 2008 Jan; 26(1):108-18. PubMed ID: 17901405
[TBL] [Abstract][Full Text] [Related]
8. Reliable identification of transition zone prostatic adenocarcinoma in preoperative needle core biopsy.
Lee S; Walsh S; Woods CG; Bonkhoff H; Cohen RJ
Hum Pathol; 2013 Oct; 44(10):2331-7. PubMed ID: 23954139
[TBL] [Abstract][Full Text] [Related]
9. Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.
Viswanath SE; Bloch NB; Chappelow JC; Toth R; Rofsky NM; Genega EM; Lenkinski RE; Madabhushi A
J Magn Reson Imaging; 2012 Jul; 36(1):213-24. PubMed ID: 22337003
[TBL] [Abstract][Full Text] [Related]
10. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate.
Zhao FJ; Han BM; Yu SQ; Xia SJ
Asian J Androl; 2009 Mar; 11(2):176-82. PubMed ID: 19122679
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland.
Noel EE; Ragavan N; Walsh MJ; James SY; Matanhelia SS; Nicholson CM; Lu YJ; Martin FL
Prostate Cancer Prostatic Dis; 2008; 11(2):173-80. PubMed ID: 17646851
[TBL] [Abstract][Full Text] [Related]
12. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
13. Identifying variables responsible for clustering in discriminant analysis of data from infrared microspectroscopy of a biological sample.
Martin FL; German MJ; Wit E; Fearn T; Ragavan N; Pollock HM
J Comput Biol; 2007 Nov; 14(9):1176-84. PubMed ID: 17990977
[TBL] [Abstract][Full Text] [Related]
14. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
[TBL] [Abstract][Full Text] [Related]
15. A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).
Tiwari P; Rosen M; Madabhushi A
Med Phys; 2009 Sep; 36(9):3927-39. PubMed ID: 19810465
[TBL] [Abstract][Full Text] [Related]
16. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.
Rosenkrantz AB; Lim RP; Haghighi M; Somberg MB; Babb JS; Taneja SS
AJR Am J Roentgenol; 2013 Oct; 201(4):W612-8. PubMed ID: 24059400
[TBL] [Abstract][Full Text] [Related]
17. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
Steuber T; Karakiewicz PI; Augustin H; Erbersdobler A; Lange I; Haese A; Chun KH; Walz J; Graefen M; Huland H
J Urol; 2005 Mar; 173(3):737-41. PubMed ID: 15711259
[TBL] [Abstract][Full Text] [Related]
18. Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker.
Wilson MJ; Haller R; Li SY; Slaton JW; Sinha AA; Wasserman NF
J Urol; 2005 Sep; 174(3):1124-8. PubMed ID: 16094078
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
20. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
